Pulse 探索 nav.journalClub 辩论趋势研究者

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

首页探索 nav.journalClub 趋势

⌘+K

August 1, 2024

View Full Paper

Advancing Precision Equity With Multicancer Detection Liquid Biopsies

NSNicholas P. SemenkovichMedical College of Wisconsin GAGautam AgarwalAugusta University ACAadel A. ChaudhuriMayo Clinic

Key Points

Key points are not available for this paper at this time.

Abstract

This Viewpoint discusses the clinical and socioeconomic potential of multicancer detection liquid biopsies.

问 AI

Like

Bookmark

Share

View Full Paper

问 AI

Like

Bookmark

Share

View Full Paper

Advancing Precision Equity With Multicancer Detection Liquid Biopsies | Synapse

Cite This Study

Semenkovich et al. (Thu,) studied this question.

synapsesocial.com/papers/68e5dfdcb6db643587574a11 https://doi.org/https://doi.org/10.1001/jamaoncol.2024.1860

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Implementation of a multi-cancer early detection (MCED) test using a centralized model within (w/i) a multi-state health system.2023 · 3 citations
2Disparities in Meeting USPSTF Breast, Cervical, and Colorectal Cancer Screening Guidelines Among Women in the United States2021 · 95 citations
3Evaluation of cell-free DNA approaches for multi-cancer early detection2022 · 316 citations
4Cell-free DNA approaches for cancer early detection and interception2023 · 84 citations
5Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set2021 · 971 citations